We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer (FACT2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01701349
Recruitment Status : Withdrawn (Expected inability to recruit study participants in a reasonable amount of time.)
First Posted : October 5, 2012
Last Update Posted : May 1, 2014
Sponsor:
Information provided by (Responsible Party):
Mateon Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : April 2017
  Estimated Study Completion Date : December 2017